Brooke Kauffman

Brooke Kauffman

Auto-generated profile, based on publicly available information

Brooke Kauffman

Department of Psychology, University of Houston

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2019 in Cognitive Behaviour Therapy
Verified
Journal Article
Closed access
ECEmily Carl
Emily Carl
SWSara M. Witcraft
Sara M. Witcraft
BKBrooke Y. Kauffman
Brooke Y. Kauffman
EGEilis M. Gillespie
Eilis M. Gillespie
EBEni S. Becker
Eni S. Becker
MPMark B. Powers
Mark B. Powers
The purpose of this meta-analysis was to provide updated pooled effect sizes of evidence-based psychotherapies and medications for generalized anxiety disorder (GAD) and to investigate potential moderators of outcomes. Seventy-nine randomized controlled trials (RCT) including 11,002 participants with a diagnosis of GAD were included in a meta-analysis that tested the efficacy of psychotherapies or medications for GAD. Psychotherapy showed a medium to large effect size (g = 0.76) and medication showed a small effect size (g = 0.38) on GAD outcomes. Psychotherapy also showed a medium effect on depression outcomes (g = 0.64) as did medications (g = 0.59). Younger age was associated with a larger effect size for psychotherapy (p < 0.05). There was evidence of publication bias in psychotherapy studies. This analysis found a medium to large effect for empirically supported psychotherapy interventions on GAD outcomes and a small effect for medications on GAD outcomes. Both groups showed a medium effect on depression outcomes. Because medication studies had more placebo control conditions than inactive conditions compared to psychotherapy studies, effect sizes between the domains should not be compared directly. Patient age should be further investigated as a potential moderator in psychotherapy outcomes in GAD.

3 October 2022 in Journal of Ethnicity in Substance Abuse
Verified
Journal Article
Closed access
MZMichael J. Zvolensky
Michael J. Zvolensky
BRBrooke Y. Redmond
Brooke Y. Redmond
TSTanya Smit
Tanya Smit
CMCameron T. Matoska
Cameron T. Matoska
NMNubia A. Mayorga
Nubia A. Mayorga
LGLorra Garey
Lorra Garey
Black individuals who smoke in the United States experience health disparities related to tobacco use (e.g., greater nicotine dependence, less success in quitting smoking) and interoceptive distress (e.g., somatic symptoms, anxiety). Individual difference factors that amplify interoceptive distress and contribute to poorer smoking behaviors and outcomes warrant further attention and investigation. Thus, the present study sought to explore the association between anxiety sensitivity and clinically-relevant smoking variables of perceived barriers for quitting, smoking inflexibility, and problems experienced during past quit attempts. Participants in the current study included 98 Black adult smokers (71.4% male; Mage = 44.08 years, SD = 11.44 years). Results indicated greater levels of anxiety sensitivity were associated with greater levels of perceived barriers for quitting smoking (b = 0.10, SE = 0.08, p = 0.01), smoking inflexibility (b = 0.02, SE <.001, p <.001), and problems experienced during past smoking quit attempts (b = 0.17, SE = 0.07, p = 0.02). Clinical implications and future directions are further discussed as it relates to anxiety sensitivity and efforts to reduce or quit smoking for this health disparities population.

12 January 2023 in Journal of Ethnicity in Substance Abuse
Verified
Journal Article
Closed access
MZMichael J. Zvolensky
Michael J. Zvolensky
JSJustin M. Shepherd
Justin M. Shepherd
BCBryce K. Clausen
Bryce K. Clausen
LGLorra Garey
Lorra Garey
BKBrooke Y. Kauffman
Brooke Y. Kauffman
ABAndre Bizier
Andre Bizier
Cigarette smoking is associated with adverse physical and mental health among Latinx adults in the United States. The present investigation sought to explore the main and interactive effects of anxiety symptoms and anxiety sensitivity in relation to cigarette dependence, perceived barriers for smoking cessation, and severity of problems experienced when quitting among adult Latinx smokers. Participants included 338 Latinx adult daily cigarette smokers (Mage = 35.53 years; SD = 8.65; age range 18–61; 37.3% female). Results indicated that anxiety symptoms were associated with greater cigarette dependence, severity of problems when quitting, and perceived barriers for smoking cessation (effect size range: 2%−3% of variance), whereas anxiety sensitivity was related to severity of problems when quitting and perceived barriers for smoking cessation (effect size range: 2%−3% of variance). There was also a statistically significant interaction between anxiety sensitivity and anxiety symptoms for cigarette dependence; anxiety was related to cigarette dependence for Latinx smokers with higher levels of anxiety sensitivity, but not for those with lower levels of anxiety sensitivity. Overall, the present findings indicate that anxiety symptoms and anxiety sensitivity are relevant factors for better understanding cigarette dependence, problems experienced when trying to quit, and perceptions of barriers to quitting among adult Latinx smokers.

16 June 2020 in Cognitive Therapy and Research
Verified
Journal Article
Closed access
PDF file
BKBrooke Y. Kauffman
Brooke Y. Kauffman
KMKara Manning
Kara Manning
ARAndrew H. Rogers
Andrew H. Rogers
LGLorra Garey
Lorra Garey
MGMatthew W. Gallagher
Matthew W. Gallagher
MZMichael J. Zvolensky
Michael J. Zvolensky

18 May 2018 in Cognitive Behaviour Therapy
Verified
Journal Article
Closed access
BKBrooke Y. Kauffman
Brooke Y. Kauffman
JBJafar Bakhshaie
Jafar Bakhshaie
HLHantin Lam
Hantin Lam
CACandice Alfano
Candice Alfano
MZMichael J. Zvolensky
Michael J. Zvolensky
There is limited understanding of the relation between insomnia and aspects of eating among college students though available data suggest salient clinical relationships. The present study explored a potential transdiagnostic mechanism in the relation between insomnia symptoms and eating expectancies. Participants were a racially/ethnically diverse sample of 1589 college students (80.4% females; Mage = 22.2 years, SD = 5.27) from an urban university. Primary analysis included three regression-based models of eating expectancies. Insomnia symptoms served as the predictor, and emotion dysregulation served as the indirect (mediator) variable in all models. Results indicated that insomnia symptoms yielded a significant indirect effect through emotion dysregulation on expectancies of eating to help manage negative affect, alleviate boredom, and lead to feeling out of control. Students experiencing insomnia symptoms may be at higher risk for experiencing dysregulated emotions and consequently maladaptive eating expectancies compared to good sleepers.

20 November 2018 in Cognitive Behaviour Therapy
Verified
Journal Article
Closed access
BKBrooke Y. Kauffman
Brooke Y. Kauffman
LGLorra Garey
Lorra Garey
ANAlec Nordan
Alec Nordan
CJCharles Jardin
Charles Jardin
NMNubia A. Mayorga
Nubia A. Mayorga
MZMichael J. Zvolensky
Michael J. Zvolensky
Currently, there is poor understanding of fatigue and the possible psychological conditions that may underlie chronic fatigue. Although substantial work has been directed to better clinically address fatigue, no work has explored individual differences in expectations or perceptions of the negative consequences associated with fatigue-related symptoms. The goals of this study were to (a) develop and (b) validate a measure of expectations or perceptions of the negative consequences associated with fatigue-related symptoms (e.g. fatigue sensitivity) across two independent samples (N = 1,827; 73.1% female; Mage = 21.68; SD = 4.54) of young adults. Results supported a 10-item measure of fatigue sensitivity, entitled the Fatigue Sensitivity Questionnaire (FSQ). The FSQ demonstrated unidimensionality, excellent internal consistency, and strong convergent and discriminant validity. Overall, the 10-item scale offers a single score that can be employed to measure fatigue sensitivity. Clinically, the FSQ may be a brief, informative, and easily disseminated measure in better understanding and capturing expectations or perceptions about the negative consequences of fatigue. As a research tool, the use of the FSQ may provide broader understanding of vulnerability factors that may influence fatigue-related health outcomes. Future research is needed to test the validity of the FSQ in other samples.